Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucuronosyltransferase | 9 | 2014 | 130 | 2.330 |
Why?
|
Alternative Splicing | 7 | 2023 | 1091 | 1.270 |
Why?
|
Multiple Myeloma | 15 | 2023 | 5131 | 1.070 |
Why?
|
RNA Precursors | 2 | 2019 | 212 | 1.010 |
Why?
|
RNA Splicing | 4 | 2023 | 915 | 1.000 |
Why?
|
fms-Like Tyrosine Kinase 3 | 9 | 2020 | 496 | 0.960 |
Why?
|
Waldenstrom Macroglobulinemia | 9 | 2014 | 1067 | 0.790 |
Why?
|
Leukemia, Myeloid, Acute | 12 | 2024 | 3605 | 0.750 |
Why?
|
Hyaluronic Acid | 2 | 2013 | 482 | 0.530 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2014 | 2824 | 0.480 |
Why?
|
Transferases | 2 | 2005 | 72 | 0.470 |
Why?
|
Receptor, Notch2 | 1 | 2014 | 87 | 0.450 |
Why?
|
Hematologic Neoplasms | 2 | 2023 | 1898 | 0.440 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13621 | 0.390 |
Why?
|
Protein Kinase Inhibitors | 9 | 2022 | 5635 | 0.370 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2013 | 685 | 0.370 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2014 | 417 | 0.370 |
Why?
|
Introns | 2 | 2008 | 976 | 0.270 |
Why?
|
Staurosporine | 4 | 2020 | 242 | 0.260 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 453 | 0.260 |
Why?
|
Molecular Targeted Therapy | 3 | 2013 | 2803 | 0.250 |
Why?
|
Thiophenes | 2 | 2020 | 587 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2020 | 8491 | 0.240 |
Why?
|
Mutant Proteins | 2 | 2019 | 492 | 0.220 |
Why?
|
Epigenesis, Genetic | 2 | 2014 | 3754 | 0.220 |
Why?
|
MicroRNAs | 1 | 2019 | 3797 | 0.210 |
Why?
|
Drug Resistance, Multiple | 1 | 2024 | 254 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2020 | 120 | 0.210 |
Why?
|
RNA, Messenger | 4 | 2014 | 12774 | 0.210 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2024 | 5214 | 0.210 |
Why?
|
Glycosyltransferases | 1 | 2003 | 118 | 0.210 |
Why?
|
Xenopus Proteins | 1 | 2003 | 434 | 0.180 |
Why?
|
STAT Transcription Factors | 1 | 2020 | 188 | 0.170 |
Why?
|
Mitosis | 4 | 2014 | 1195 | 0.170 |
Why?
|
Janus Kinases | 1 | 2020 | 249 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2022 | 346 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2022 | 556 | 0.150 |
Why?
|
Neoplasms | 3 | 2014 | 22019 | 0.150 |
Why?
|
Paraproteinemias | 2 | 2014 | 246 | 0.150 |
Why?
|
Glutarates | 1 | 2018 | 244 | 0.140 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2010 | 431 | 0.140 |
Why?
|
Mutation | 8 | 2020 | 29877 | 0.140 |
Why?
|
Leukemia, Myeloid | 1 | 2020 | 696 | 0.140 |
Why?
|
Apoptosis | 6 | 2024 | 9492 | 0.130 |
Why?
|
Leukemia, B-Cell | 1 | 2016 | 84 | 0.130 |
Why?
|
Cell Line, Tumor | 13 | 2020 | 16871 | 0.130 |
Why?
|
Breast Neoplasms | 3 | 2022 | 21022 | 0.120 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12580 | 0.120 |
Why?
|
Mitochondria | 2 | 2020 | 3600 | 0.120 |
Why?
|
Piperidines | 3 | 2020 | 1649 | 0.110 |
Why?
|
Pyrimidines | 4 | 2020 | 2996 | 0.110 |
Why?
|
Gene Expression Profiling | 4 | 2014 | 9374 | 0.110 |
Why?
|
Acrylamides | 1 | 2015 | 259 | 0.110 |
Why?
|
Humans | 43 | 2024 | 759255 | 0.110 |
Why?
|
Sirtuins | 1 | 2015 | 320 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2723 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 922 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 778 | 0.100 |
Why?
|
Membrane Proteins | 2 | 2014 | 7851 | 0.100 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 727 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2019 | 729 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 525 | 0.090 |
Why?
|
Genetic Variation | 3 | 2014 | 6531 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4573 | 0.090 |
Why?
|
Sulfonamides | 1 | 2020 | 1972 | 0.090 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2014 | 645 | 0.090 |
Why?
|
Disease Progression | 4 | 2014 | 13479 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2007 | 809 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3730 | 0.080 |
Why?
|
Cluster Analysis | 2 | 2014 | 2698 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 2 | 2004 | 829 | 0.080 |
Why?
|
Electrophoresis, Capillary | 2 | 2009 | 63 | 0.080 |
Why?
|
Signal Transduction | 7 | 2020 | 23362 | 0.080 |
Why?
|
Benzothiazoles | 2 | 2020 | 246 | 0.080 |
Why?
|
Hematopoietic System | 1 | 2008 | 109 | 0.080 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2015 | 649 | 0.080 |
Why?
|
Animals | 14 | 2024 | 167838 | 0.080 |
Why?
|
Nucleosides | 1 | 2008 | 131 | 0.080 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 2056 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2014 | 15750 | 0.080 |
Why?
|
Drug Design | 1 | 2013 | 1062 | 0.080 |
Why?
|
Prognosis | 7 | 2018 | 29561 | 0.080 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 367 | 0.080 |
Why?
|
Genes, Regulator | 1 | 2009 | 374 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1756 | 0.070 |
Why?
|
src-Family Kinases | 1 | 2010 | 534 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 2 | 2005 | 1827 | 0.070 |
Why?
|
Cell Line | 2 | 2014 | 15636 | 0.070 |
Why?
|
Leukemia | 1 | 2015 | 1511 | 0.070 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2007 | 286 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3603 | 0.070 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 377 | 0.070 |
Why?
|
Phenylurea Compounds | 2 | 2020 | 529 | 0.070 |
Why?
|
Thiazoles | 2 | 2011 | 1501 | 0.070 |
Why?
|
Polymerase Chain Reaction | 2 | 2005 | 6070 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2019 | 717 | 0.070 |
Why?
|
Electrophoresis, Microchip | 1 | 2005 | 11 | 0.070 |
Why?
|
DNA Damage | 1 | 2015 | 2442 | 0.060 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13456 | 0.060 |
Why?
|
Thalidomide | 1 | 2011 | 884 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3724 | 0.060 |
Why?
|
Plasma Cells | 1 | 2009 | 591 | 0.060 |
Why?
|
Point Mutation | 1 | 2010 | 1594 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9269 | 0.060 |
Why?
|
Bone Marrow | 3 | 2020 | 2918 | 0.060 |
Why?
|
Mice | 9 | 2024 | 81138 | 0.060 |
Why?
|
Codon, Terminator | 1 | 2005 | 125 | 0.060 |
Why?
|
Electrophoresis | 1 | 2004 | 234 | 0.060 |
Why?
|
Granulocyte Precursor Cells | 1 | 2024 | 49 | 0.060 |
Why?
|
Benzimidazoles | 2 | 2020 | 858 | 0.060 |
Why?
|
Aniline Compounds | 2 | 2020 | 1058 | 0.060 |
Why?
|
Bone Marrow Cells | 3 | 2011 | 2424 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2007 | 755 | 0.060 |
Why?
|
Pyrazines | 2 | 2020 | 1201 | 0.060 |
Why?
|
Drug Synergism | 2 | 2020 | 1755 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 17750 | 0.050 |
Why?
|
Codon | 1 | 2005 | 602 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1344 | 0.050 |
Why?
|
Piperazines | 2 | 2011 | 2517 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2014 | 1627 | 0.050 |
Why?
|
Exons | 1 | 2008 | 2389 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2020 | 10440 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3774 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4716 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2003 | 201 | 0.050 |
Why?
|
Burkitt Lymphoma | 1 | 2004 | 333 | 0.050 |
Why?
|
Translocation, Genetic | 1 | 2007 | 1388 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17629 | 0.050 |
Why?
|
Up-Regulation | 2 | 2011 | 4132 | 0.050 |
Why?
|
Cell Survival | 3 | 2017 | 5796 | 0.040 |
Why?
|
DNA Primers | 1 | 2005 | 2817 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2014 | 64879 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2005 | 1744 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2014 | 4733 | 0.040 |
Why?
|
Genotype | 3 | 2014 | 12940 | 0.040 |
Why?
|
Molecular Structure | 2 | 2017 | 1895 | 0.040 |
Why?
|
Gene Expression | 3 | 2015 | 7593 | 0.040 |
Why?
|
Pyrazoles | 2 | 2020 | 1989 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2005 | 4171 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2007 | 1588 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2007 | 2377 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2017 | 6131 | 0.040 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1395 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1690 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2007 | 1588 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11653 | 0.040 |
Why?
|
Blotting, Western | 1 | 2005 | 5039 | 0.040 |
Why?
|
Triazines | 1 | 2019 | 311 | 0.040 |
Why?
|
Base Sequence | 1 | 2008 | 12450 | 0.040 |
Why?
|
Software | 1 | 2011 | 4421 | 0.030 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2015 | 39 | 0.030 |
Why?
|
Ligands | 1 | 2003 | 3275 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3584 | 0.030 |
Why?
|
Nitriles | 1 | 2020 | 954 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20031 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4491 | 0.030 |
Why?
|
Ubiquitination | 1 | 2020 | 1009 | 0.030 |
Why?
|
Mutagens | 1 | 2015 | 178 | 0.030 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2015 | 84 | 0.030 |
Why?
|
Niacin | 1 | 2015 | 119 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2015 | 295 | 0.030 |
Why?
|
Stromal Cells | 2 | 2011 | 1327 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2014 | 184 | 0.030 |
Why?
|
Unfolded Protein Response | 1 | 2015 | 233 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1836 | 0.030 |
Why?
|
Niacinamide | 1 | 2015 | 414 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1062 | 0.030 |
Why?
|
Pyrroles | 1 | 2019 | 1135 | 0.030 |
Why?
|
Mice, Nude | 2 | 2010 | 3605 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 286 | 0.030 |
Why?
|
Female | 8 | 2022 | 390240 | 0.030 |
Why?
|
Ubiquitin | 1 | 2017 | 838 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1229 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3087 | 0.020 |
Why?
|
Dioxygenases | 1 | 2014 | 342 | 0.020 |
Why?
|
Enzyme Stability | 1 | 2011 | 220 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2009 | 21988 | 0.020 |
Why?
|
NAD | 1 | 2015 | 611 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 1002 | 0.020 |
Why?
|
DNA | 1 | 2005 | 7237 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2011 | 351 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2011 | 251 | 0.020 |
Why?
|
Half-Life | 1 | 2011 | 652 | 0.020 |
Why?
|
Syndecan-1 | 1 | 2011 | 163 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 384 | 0.020 |
Why?
|
Threonine | 1 | 2010 | 272 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18968 | 0.020 |
Why?
|
Chlorambucil | 1 | 2008 | 42 | 0.020 |
Why?
|
Cladribine | 1 | 2008 | 34 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2203 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12800 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 1994 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1483 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 1771 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18110 | 0.020 |
Why?
|
Autophagy | 1 | 2016 | 1336 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5120 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2018 | 58867 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3810 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2011 | 563 | 0.020 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.020 |
Why?
|
Vidarabine | 1 | 2008 | 336 | 0.020 |
Why?
|
Immunoblotting | 1 | 2010 | 1649 | 0.020 |
Why?
|
Tyrosine | 1 | 2011 | 1440 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2866 | 0.020 |
Why?
|
DNA Repair | 1 | 2015 | 2039 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5427 | 0.020 |
Why?
|
Aged | 6 | 2018 | 168617 | 0.020 |
Why?
|
Immunoglobulin Fragments | 1 | 2005 | 85 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1737 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 370 | 0.020 |
Why?
|
Templates, Genetic | 1 | 2005 | 190 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2582 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10827 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11908 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 2005 | 323 | 0.010 |
Why?
|
Benzamides | 1 | 2010 | 1369 | 0.010 |
Why?
|
Middle Aged | 6 | 2018 | 219653 | 0.010 |
Why?
|
Semiconductors | 1 | 2004 | 99 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9194 | 0.010 |
Why?
|
Microelectrodes | 1 | 2004 | 304 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74167 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4463 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2852 | 0.010 |
Why?
|
Time Factors | 1 | 2005 | 40109 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39216 | 0.010 |
Why?
|
Cell Size | 1 | 2004 | 623 | 0.010 |
Why?
|
Mice, SCID | 1 | 2007 | 2628 | 0.010 |
Why?
|
Cell Cycle | 1 | 2010 | 2939 | 0.010 |
Why?
|
Drug Discovery | 1 | 2010 | 1054 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2005 | 7595 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2004 | 748 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2008 | 1376 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14652 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2048 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2010 | 2559 | 0.010 |
Why?
|
Phosphorylation | 1 | 2011 | 8313 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11123 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6532 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1783 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9466 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1695 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5793 | 0.010 |
Why?
|
Adult | 4 | 2018 | 219390 | 0.010 |
Why?
|
Male | 5 | 2018 | 358719 | 0.010 |
Why?
|
Graft Survival | 1 | 2007 | 3789 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9590 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12522 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9528 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54204 | 0.010 |
Why?
|
Genome, Human | 1 | 2005 | 4412 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 58483 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11476 | 0.010 |
Why?
|
Survival Analysis | 1 | 2004 | 10185 | 0.010 |
Why?
|
Incidence | 1 | 2008 | 21336 | 0.010 |
Why?
|
Algorithms | 1 | 2007 | 13946 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2008 | 80121 | 0.000 |
Why?
|